Dendritic cells or their exosomes are effective biotherapies of cancer

European Journal of Cancer

Volumn 35, Issue SUPPL. 3, 1999, Pages 36-38

  Zitvogel, L ^a   Fernandez, N ^a   Lozier, A ^a   Wolfers, J ^a   Regnault, A ^b   Raposo, G ^c   Amigorena, S ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSTITUT CURIE   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; CANCER IMMUNOTHERAPY; CONFERENCE PAPER; DENDRITIC CELL; HUMAN; LYSOSOME; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

DENDRITIC CELLS; HUMANS; IMMUNIZATION, PASSIVE; KILLER CELLS, NATURAL; NEOPLASMS;

EID: 0032768005     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00090-8     Document Type: Conference Paper

References (11)

1. Mayordomo J.I., Zorina T., Storkus W.J.et al. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Med. 1:1995;1297-1302.
2. Zitvogel L., Mayordomo J.I., Tjandrawan T.et al. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 183:1996;87-97.
3. Lynch D.H., Andreasen A., Maraskovsky E., Whitmore J., Miller R.E., Schuh J.C.L. Flt3 ligand induces tumor regression and antitumor immune responses in vivo. Nature Med. 3:1997;625-631.
4. Nijman H., Kleijmeer M., Ossevoort M.et al. Antigen capture and MHC class II compartments in freshly isolated and cultured blood dendritic cells. J. Exp. Med. 182:1995;163-174.
5. Kleijmeer M., Ossevoort M., Veen C.V.et al. MHC class II compartments and the kinetics of antigen presentation in activated mouse spleen dendritic cells. J Immunol. 154:1995;5715-5724.
6. Raposo G., Nijman H., Stoorvogel W.et al. B lymphocytes secrete antigen presenting vesicles. J. Exp. Med. 183:1996;1161-1172.
7. Kleijmeer M, Escola JM, Griffith J, Geuze H. MHC class I molecules are present in MHC class II compartments from dendritic cells and B lymphocytes. Cellular and Molecular Biology of Dendritic Cells. Keystone Symposia. 1998, Abst. 220, 64.
8. Zitvogel L., Regnault A., Lozier A.et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nature Med. 4:1998;594-600.
9. Winzler C., Rovere P., Rescigno M.et al. Maturation stages of mouse dendritic cells in growth factor-dependent long term cultures. J. Exp. Med. 185:1997;317-328.
10. Shaw S.G., Maung A.A., Steptoe R.J., Thomson A.W., Vujanovic N.L. Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3L: implications for anticancer and antiviral therapy. J. Immunol. 161:1998;2817-2824.
11. Fernandez N.C., Lozier A., Flament C.et al. Dendritic cells directly trigger NK cell functions: a cross-talk relevant in innate antitumor immune responses in vivo. Nature Med. 5:1999;405-411.